Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

metlife inc. - MET

MET

Close Chg Chg %
94.36 0.06 0.06%

Closed Market

94.42

+0.06 (0.06%)

Volume: 2.98M

Last Updated:

Oct 2, 2026, 3:59 PM EDT

Trade Now

Company Overview: metlife inc. - MET

MET Key Data

Open

$94.28

 Day Range

94.07 - 94.94

52 Week Range

67.33 - 100.93

 Market Cap

$59.84B

Shares Outstanding

635.48M

 Public Float

531.46M

Beta

0.77

 Rev. Per Employee

N/A

P/E Ratio

18.02

 EPS

$5.26

Yield

245.89%

 Dividend

$0.59

EX-DIVIDEND DATE

Aug 4, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

3.13M

  

MET Performance

1 Week
 
 -3.35%
 
1 Month
 
 -3.27%
 
3 Months
 
 4.85%
 
1 Year
 
 14.64%
 
5 Years
 
 51.04%
 

MET Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 22
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 107.20
Number of Ratings 22 Current Quarters Estimate 2.628
FY Report Date 12 / 2026 Current Year's Estimate 10.136
Last Quarter’s Earnings 2.619 Median PE on CY Estimate N/A
Year Ago Earnings 8.83 Next Fiscal Year Estimate 11.141
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 14 18 18
Mean Estimate 2.63 2.56 10.14 11.14
High Estimates 2.87 2.81 10.50 11.63
Low Estimate 2.45 2.39 9.85 10.76
Coefficient of Variance 4.23 4.73 1.91 2.65

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 12 11
OVERWEIGHT 3 3 3
HOLD 6 6 6
UNDERWEIGHT 1 1 2
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Metlife Inc. - MET

Date Name Shares Transaction Value
Sep 11, 2026 William E. Kennard Director 47,704 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 4,555,732.00
Sep 11, 2026 Robert Glenn Hubbard Director 108,191 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 10,332,240.50
Sep 11, 2026 Daniel S. Glaser Director 2,705 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 258,327.50
Sep 11, 2026 Christian Mumenthaler Director 3,474 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 331,767.00
Sep 11, 2026 Carla A. Harris Director 11,157 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 1,065,493.50
Sep 11, 2026 Diana L. McKenzie Director 25,385 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 2,424,267.50
Sep 11, 2026 Jeh Charles Johnson Director 9,557 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 912,693.50
Sep 11, 2026 Ramy Tadros President, U.S. Business 212,695 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 20,312,372.50
Sep 11, 2026 Laura J. Hay Director 6,357 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $95.5 per share 607,093.50

Metlife Inc. in the News